Leer esta página en español

Herceptin (chemical name: trastuzumab) can be an effective treatment both before and after surgery for people with HER2-positive breast cancer. It has also been shown to reduce the risk of breast cancer recurrence after initial surgery.

In this section you can learn more about:

To connect with others with HER2-positive breast cancer, join the Breastcancer.org Discussion Board HER2-Positive Breast Cancer forum.

Was this resource helpful?

Yes No
Back to Top